Aberrant fatty acid biosynthesis, often driven by upregulation or mutation of FASN, promotes membrane biosynthesis, oncogenic signaling, and lipid-mediated protection from oxidative stress, supporting tumor growth and resistance to apoptosis (Figures 3B, C) (22–24). The gene discussed is FASN; the disease is neoplasm.